¸ñÀû: Methicillin-resistant Staphylococcus aureus (MRSA) biofilms on
tympanostomy tubes are a major cause of persistent and refractory post-
tympanostomy tube otorrhea (PTTO). This study investigated the in vitro
antibacterial and antibiofilm effects of multifungin against MRSA
associated with tympanostomy tubes. ¹æ¹ý:The antibacterial and antibiofilm activities of multifungin were
evaluated using MRSA biofilms through bacterial growth inhibition
assays, adhesion assays, biofilm formation and eradication assays,
biofilm hydrolytic activity assays, and wheat germ agglutinin (WGA)
fluorescence analysis. In addition, the antibiofilm efficacy of varying
concentrations of multifungin against MRSA biofilms formed on
tympanostomy tubes was assessed using scanning electron microscopy. °á°ú:Multifungin exhibited potent antibacterial activity against MRSA, with
a minimum inhibitory concentration of 1.0 µM. Multifungin
significantly inhibited MRSA biofilm formation and effectively reduced
bacterial adhesion in a concentration-dependent manner. In preformed
mature MRSA biofilms, multifungin enhanced biofilm eradication,
reduced metabolic activity as shown by decreased fluorescein diacetate
hydrolysis and ATP levels, and markedly decreased residual biofilm
biomass. Multifungin also disrupted the MRSA biofilm extracellular
polymeric matrix, demonstrated by reduced WGA fluorescence intensity.
Scanning electron microscopy revealed substantial, concentration-
dependent reductions in MRSA biofilms and bacterial colonies on
tympanostomy tube surfaces following multifungin treatment. °á·Ð:Multifungin demonstrated strong antibacterial, antibiofilm, and
biofilm-eradication activities against MRSA, including biofilms formed
on tympanostomy tubes. These findings indicate that multifungin has
significant potential as a repurposed antimicrobial agent for treating
PTTO caused by MRSA infection and biofilm formation. |